초상자성 입자 시장 보고서(2026년)
Superparamagnetic Particles Global Market Report 2026
상품코드 : 1927283
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

초상자성 입자 시장 규모는 최근 급성장을 이루고 있습니다. 2025년 13억 8,000만 달러에서 2026년에는 15억 5,000만 달러에 이르고, CAGR 12.1%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 의료영상기술의 발전, 나노기술 연구의 확대, 생체의료 진단 수요, 실험실 분리기술, 재료과학의 혁신에 기인한 것으로 분석되고 있습니다.

초상자성 입자 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 24억 3,000만 달러에 이르고, CAGR은 11.9%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 정밀의료 도입, 첨단 약물 전달 시스템, 바이오센서 개발, 의료 진단 확대, 나노 의료 연구 자금 투입 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 MRI 조영제로서의 이용 증가, 표적 약물 전달 시스템으로의 채택 확대, 자기 분리 기술의 발전, 나노 스케일 입자 설계에 대한 관심 증가, 표면 기능화의 진전 등을 들 수 있습니다.

맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 초자성 입자 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료란 치료 결과의 향상과 부작용을 최소화하기 위해 개인의 유전자 프로파일, 생활습관, 환경에 따라 치료와 의료적 판단을 맞춤화하는 의료적 접근을 말합니다. 유전자 검사와 정밀 진단 기술의 발전으로 의료 전문가가 환자별로 치료법을 조정할 수 있게 되면서 개인 맞춤형 의료에 대한 수요가 증가하고 있습니다. 초자성 입자는 표적 약물 전달, 분자 이미징, 진단 용도를 지원함으로써 맞춤형 의료에 중요한 역할을 하며, 궁극적으로 치료 성과 향상에 기여합니다. 예를 들어, 2024년 2월 미국 비영리단체 '맞춤의료연합'이 발표한 보고서에 따르면, 2023년 미국 식품의약국(FDA)이 승인한 희귀질환에 대한 신규 맞춤치료제는 16건(2022년 6건)에 달했으며, 이 중 7건은 암 치료, 3건은 기타 질환에 대한 치료였습니다. 이처럼 개인 맞춤형 의료에 대한 수요 증가가 초자성 입자 시장의 성장을 견인하고 있습니다.

초자성 입자 시장에서 사업을 전개하는 주요 기업들은 비침습적으로 체내 구조를 가시화하기 위한 조영제 등 첨단 솔루션 개발에 주력하고 있습니다. 조영제란 의료영상에서 특정 조직이나 장기의 대비를 향상시켜 진단의 정확도를 높이는 물질입니다. 예를 들어, 2023년 12월 호주의 의료 영상 기업 Imagion Biosystems는 자체 개발한 IBI10103의 임상 1상 시험이 완료됨에 따라 좋은 결과를 발표했습니다. 본 임상시험은 HER2 양성 원발성 유방암 환자에서 겨드랑이 림프절 전이를 검출하기 위한 MRI 보조제로서 MagSense HER2 영상제(MSH2IA)의 안전성 및 임상적 타당성을 평가하였습니다. 이 이미징제는 캘리포니아 샌디에이고에 위치한 Imagion사의 GMP 준수 시설에서 제조된 초자성 산화철 나노입자를 핵심으로 구성되어 있습니다. 나노입자는 생체적합성 고분자로 코팅되어 있으며, 단일클론항체 트러스투주맙(허셉틴)과 결합되어 있습니다. MSH2IA는 원발성 종양 부위 부근에 1회 주사하여 림프계를 이동하면서 HER2 양성 유방암 세포에 선택적으로 결합하여 MRI 이미지의 가시성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 세계 전체 시장(TAM) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

LSH
영문 목차

영문목차

Superparamagnetic particles are nanosized magnetic materials, typically composed of iron oxides, that exhibit magnetic properties only when exposed to an external magnetic field. They become magnetized in the presence of the field but lose magnetization once the field is removed. Owing to their small size and strong magnetic responsiveness, they are extensively utilized in biomedical applications such as MRI contrast agents, drug delivery, and magnetic separation.

The primary types of superparamagnetic particles include iron oxide particles, cobalt ferrite particles, nickel ferrite particles, magnetite particles, and others. Iron oxide particles refer to minute particles composed of iron and oxygen that possess magnetic characteristics and are commonly used in biomedical, industrial, and environmental applications. They are available in various sizes, including nanoscale (less than 100 nm), microscale (100 nm to 1 μm), and sub-microscale (1 μm to 10 μm), and are distributed through direct sales, distributors and resellers, online retailers, and third-party platforms. They find applications in biomedical uses, magnetic resonance imaging (MRI), drug delivery systems, biosensors, and magnetic separation, serving end-user industries such as healthcare and life sciences, environmental applications, the food and beverage industry, electronics and consumer goods, and chemicals and pharmaceuticals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the superparamagnetic particles market by increasing costs of imported raw materials and nanoparticle synthesis equipment. These impacts are most significant in biomedical and life sciences applications across North America and Europe. Higher tariffs have affected research and clinical supply chains. However, tariffs have encouraged regional nanoparticle manufacturing capabilities. This has supported localized production and improved research accessibility.

The superparamagnetic particles market research report is one of a series of new reports from The Business Research Company that provides superparamagnetic particles market statistics, including superparamagnetic particles industry global market size, regional shares, competitors with a superparamagnetic particles market share, detailed superparamagnetic particles market segments, market trends and opportunities, and any further data you may need to thrive in the superparamagnetic particles industry. This superparamagnetic particles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The superparamagnetic particles market size has grown rapidly in recent years. It will grow from $1.38 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to medical imaging advancements, nanotechnology research growth, biomedical diagnostics demand, laboratory separation techniques, material science innovation.

The superparamagnetic particles market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to precision medicine adoption, advanced drug delivery systems, biosensor development, healthcare diagnostics expansion, nano medicine research funding. Major trends in the forecast period include rising use in mri contrast imaging, growing adoption in targeted drug delivery, expansion in magnetic separation techniques, increased focus on nano scale particle design, advancements in surface functionalization.

The growing demand for personalized medicine is expected to drive the expansion of the superparamagnetic particles market in the coming years. Personalized medicine refers to a medical approach that customizes treatment and healthcare decisions based on an individual's genetic profile, lifestyle, and environment to enhance treatment outcomes and minimize side effects. The demand for personalized medicine is increasing due to advancements in genetic testing and precision diagnostics, which enable healthcare professionals to tailor therapies for each patient. Superparamagnetic particles play a key role in personalized medicine by supporting targeted drug delivery, molecular imaging, and diagnostic applications, ultimately contributing to improved therapeutic results. For instance, in February 2024, the Personalized Medicine Coalition, a United States-based non-profit organization, reported that in 2023, the United States Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases, up from six in 2022, including seven cancer therapies and three for other medical conditions. Therefore, the growing demand for personalized medicine is driving the growth of the superparamagnetic particles market.

Key companies operating in the superparamagnetic particles market are focusing on developing advanced solutions, such as imaging agents, to enable non-invasive visualization of internal body structures. Imaging agents are substances that enhance the contrast of specific tissues or organs in medical imaging to improve diagnostic accuracy. For instance, in December 2023, Imagion Biosystems Limited, an Australia-based medical imaging company, announced positive outcomes following the completion of its IBI10103 phase I clinical trial. The study evaluated the safety and clinical feasibility of the MagSense HER2 Imaging Agent (MSH2IA) as an adjunct to MRI for detecting axillary lymph node metastasis in patients with HER2-positive primary breast cancer. This imaging agent is based on a core of superparamagnetic iron oxide nanoparticles produced at Imagion's GMP-compliant facility in San Diego, California. The nanoparticles are coated with biocompatible polymers and conjugated to the monoclonal antibody trastuzumab (Herceptin). MSH2IA is administered as a single injection near the primary tumor site and travels through the lymphatic system, selectively binding to HER2-positive breast cancer cells to improve MRI visualization.

In July 2024, Hologic Inc., a United States-based medical technology company, acquired Endomagnetics Ltd. for 310 million dollars. Through this acquisition, Hologic aims to enhance and diversify its oncology portfolio by incorporating Endomagnetics Ltd's magnetic surgical technologies, thereby strengthening its expertise in advanced cancer diagnostics, minimally invasive treatment solutions, and comprehensive patient care across multiple oncological fields. Endomagnetics Ltd. is a United Kingdom-based manufacturer of products containing superparamagnetic particles.

Major companies operating in the superparamagnetic particles market are Thermo Fisher Scientific Inc., Miltenyi Biotec B.V. & Co. KG, Spherotech Inc., nanoComposix Inc., Nanoshel LLC, Cytodiagnostics Inc., Micromod Partikeltechnologie GmbH, Ocean NanoTech LLC, MagQu Co. Ltd., Bang Laboratories, JSR Life Sciences LLC, BioVision Inc., Creative Diagnostics, Ademtech SAS, Chemicell GmbH, Bangs Laboratories Inc., NanoMagnetics Ltd., Sphere Fluidics Ltd., Fluidic Analytics Ltd., Bio-Rad Laboratories Inc., Bio-Nano Consulting Ltd.

North America was the largest region in the superparamagnetic particles market in 2025. The regions covered in the superparamagnetic particles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the superparamagnetic particles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The superparamagnetic particles market consists of sales of dynabeads, magnetic separators and racks, dextran-coated magnetic beads, magnetic hyperthermia nanoparticles, and silica-coated magnetic nanoparticles. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Superparamagnetic Particles Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses superparamagnetic particles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for superparamagnetic particles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The superparamagnetic particles market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Superparamagnetic Particles Market Characteristics

3. Superparamagnetic Particles Market Supply Chain Analysis

4. Global Superparamagnetic Particles Market Trends And Strategies

5. Superparamagnetic Particles Market Analysis Of End Use Industries

6. Superparamagnetic Particles Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Superparamagnetic Particles Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Superparamagnetic Particles Total Addressable Market (TAM) Analysis for the Market

9. Superparamagnetic Particles Market Segmentation

10. Superparamagnetic Particles Market Regional And Country Analysis

11. Asia-Pacific Superparamagnetic Particles Market

12. China Superparamagnetic Particles Market

13. India Superparamagnetic Particles Market

14. Japan Superparamagnetic Particles Market

15. Australia Superparamagnetic Particles Market

16. Indonesia Superparamagnetic Particles Market

17. South Korea Superparamagnetic Particles Market

18. Taiwan Superparamagnetic Particles Market

19. South East Asia Superparamagnetic Particles Market

20. Western Europe Superparamagnetic Particles Market

21. UK Superparamagnetic Particles Market

22. Germany Superparamagnetic Particles Market

23. France Superparamagnetic Particles Market

24. Italy Superparamagnetic Particles Market

25. Spain Superparamagnetic Particles Market

26. Eastern Europe Superparamagnetic Particles Market

27. Russia Superparamagnetic Particles Market

28. North America Superparamagnetic Particles Market

29. USA Superparamagnetic Particles Market

30. Canada Superparamagnetic Particles Market

31. South America Superparamagnetic Particles Market

32. Brazil Superparamagnetic Particles Market

33. Middle East Superparamagnetic Particles Market

34. Africa Superparamagnetic Particles Market

35. Superparamagnetic Particles Market Regulatory and Investment Landscape

36. Superparamagnetic Particles Market Competitive Landscape And Company Profiles

37. Superparamagnetic Particles Market Other Major And Innovative Companies

38. Global Superparamagnetic Particles Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Superparamagnetic Particles Market

40. Superparamagnetic Particles Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기